GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Engmann Lawrence   Benadiva Claudio  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3258-3260

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist protocol administration in the luteal phase in ICSIET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study

By Ata B.   Yakin K.   Balaban B.   Urman B.  

Human Reproduction, Vol. 23, Iss. 3, 2008-03 ,pp. : 668-673

Oxford University Press

Access to resources Recommend Favorite

Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial

By Galindo Anna   Bodri Daniel   Guillén Juan José   Colodrón Marta   Vernaeve Valérie   Coll Oriol  

Gynecological Endocrinology, Vol. 25, Iss. 1, 2009-06 ,pp. : 60-66

Informa Healthcare

Access to resources Recommend Favorite

Ovarian stimulation in women with high and normal body mass index: GnRH agonist versus GnRH antagonist

By Marci Roberto   Lisi Franco   Soave Ilaria   Lo Monte Giuseppe   Patella Alfredo   Caserta Donatella   Moscarini Massimo  

Gynecological Endocrinology, Vol. 28, Iss. 10, 2012-10 ,pp. : 792-795

Informa Healthcare

Access to resources Recommend Favorite

GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels

By Orvieto Raoul   Nahum Ravit   Meltzer Simion   Liberty Gadi   Anteby Eyal Y.   Zohav Efraim  

Gynecological Endocrinology, Vol. 29, Iss. 9, 2013-09 ,pp. : 843-845

Informa Healthcare

Access to resources Recommend Favorite